Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.

[1]  P. Wen,et al.  Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. , 1995, Neurosurgery.

[2]  M. Mehta,et al.  Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. , 1994, International journal of radiation oncology, biology, physics.

[3]  M. Prados,et al.  Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. , 1994, International journal of radiation oncology, biology, physics.

[4]  S. Ashley,et al.  Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy. , 1994, European journal of cancer.

[5]  W. Curran,et al.  Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R. Laing,et al.  Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study). , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  David G. T. Thomas,et al.  Stereotactic And Image Directed Surgery of Brain Tumours , 1993 .

[8]  P. Gutin,et al.  Selection bias, survival, and brachytherapy for glioma. , 1992, Journal of neurosurgery.

[9]  A. Nahum,et al.  A comparison of techniques for stereotactic radiotherapy by linear accelerator based on 3-dimensional dose distributions. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  A P Warrington,et al.  Relocatable frame for stereotactic external beam radiotherapy. , 1991, International journal of radiation oncology, biology, physics.

[11]  P. Wen,et al.  Results of radiosurgery used in the initial management of patients with malignant gliomas , 1991 .

[12]  H. Kooy,et al.  Variables associated with the development of complications from radiosurgery of intracranial tumors. , 1991, International journal of radiation oncology, biology, physics.

[13]  P. Gutin,et al.  Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. , 1989, International journal of radiation oncology, biology, physics.

[14]  S B Green,et al.  The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[16]  Mahoney Fi,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 1965 .

[17]  F. I. Mahonery.  Functional evaluation : Barthel index , 1965 .

[18]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[19]  Harlan I. Firminger,et al.  Atlas of tumor pathology , 1954 .